📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

A Phase II study of neoadjuvant axitinib for reducing the extent of venous tumour thrombus in clear cell renal cell cancer with venous invasion (NAXIVA). (2022)

First Author: Stewart GD

Attributed to: Cambridge Mathematics of Information in Healthcare (CMIH) funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41416-022-01883-7

PubMed Identifier: 35739300

Publication URI: http://europepmc.org/abstract/MED/35739300

Type: Journal Article/Review

Volume: 127

Parent Publication: British journal of cancer

Issue: 6

ISSN: 0007-0920